[Pharmacokinetic characteristics and biodegradation of aprindin in man].
D000284:Administration, Oral; D000814:Aniline Compounds / Q000378:metabolism / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000378:metabolism* / Q000494:pharmacology; D001711:Biotransformation; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D004048:Diethylamines / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D007192:Indenes / Q000378:metabolism* / Q000494:pharmacology; D007275:Injections, Intravenous; D013058:Mass Spectrometry; D014316:Tritium
D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents; D004048:Diethylamines; D007192:Indenes; D014316:Tritium
Caractéristiques pharmacocinétiques et biodégradation de l'aprindine chez l'homme